Brief: Galapagos Announces Strategic Update On Proposed Separation, Leadership Transition, Board Changes
May 13 (Reuters) - Galapagos NV GLPG.AS: GALAPAGOS ANNOUNCES STRATEGIC UPDATE ON PROPOSED SEPARATION, EXECUTIVE LEADERSHIP TRANSITION AND BOARD CHANGES TO EXPLORE STRATEGIC ALTERNATIVES FOR EXISTING BUSINESSES TO RE-EVALUATE SEPARATION PLAN DUE TO MARKET DEVELOPMENTS HENRY GOSEBRUCH APPOINTED AS CEO OF GALAPAGOS PAUL STOFFELS TO REMAIN AS ADVISOR FOR GALAPAGOS JÉRÔME CONTAMINE APPOINTED AS CHAIR OF GALAPAGOS BOARD Source text: ID:nGNX7Xg1bF Further company coverage: GLPG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline